Curza Virtual Presentation to Active Angel Network

About Curza

Everyone gets an infection at some point during the year, and there are 2.8 million anti-microbial infections (AMR) annually. It can affect anyone, of any age, in any country. The antibiotics used to treat these infections are losing their efficacy and there are 5 million AMR deaths annually.

Cūrza is a small-molecule therapeutics company that has developed several structurally distinct classes of proprietary drugs focused on infectious diseases. Cūrza's goal is to develop novel classes of antibiotics that combat the rising epidemic of antibiotic resistance that now contributes to the death of 5,000,000 people each year.

Register and join us on Wednesday December 10th, 2025, at noon to learn more about Curza.